SAN DIEGO--(BUSINESS WIRE)--International Stem Cell Institute (http://www.iStemCelli.com), a worldwide leader in Stem Cell Therapy, today announces the launch of its significant and proprietary Adipose-derived Adult Stem Cell Therapy program, declaring it an extremely effective solution to treat degenerative diseases and conditions. Scientists and medical researchers worldwide are finding adult stem cells have an almost magical ability to heal the human body, and the supporting scientific evidence is rapidly mounting. The FDA recently approved Geron Corporation and University of California at Irvine to conduct trials utilizing embryonic stem cells in patients with spinal cord injuries. However after ten years of rigorous testing and research on embryonic stem cells, scientists have still not been able to treat or cure any diseases. By comparison, adult stem cells continue to show their ability to successfully treat human disease and injury, while embryonic stem cells continue to demonstrate zero benefits for humans, and only limited results in animal models. It’s now widely accepted Adult Stem Cells hold the real key to curing diseases and medical conditions and are the future direction of medicine. ISCI’s treatments—based solely on Adult Stem Cells—utilize leading edge technologies, and hold immediate promise for patients suffering from many forms of degenerative diseases.
